AHR vs WELL
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
AHR · American Healthcare REIT$57.91 ▲ 3.34%
WELL · Welltower$245.01 ▼ 0.17%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- AHR +19.8%
- WELL +29.6%
Head to head
| Metric | AHR | WELL |
|---|---|---|
| Price | $57.91 | $245.01 |
| Change today | ▲ 3.34% | ▼ 0.17% |
| Market cap | $13.40B | $179.74B |
| Return, 3 months | +4.9% | +4.6% |
| Return, year to date | +24.9% | +33.4% |
| Return, 1 year | +19.6% | +30.7% |
| P/E (TTM) | 118.2 | 107.0 |
| P/B | 2.4 | 3.7 |
| P/E percentile vs own 5y | 85th | 32nd |
| Dividend yield | 1.73% | 1.25% |
| Revenue growth (YoY, latest qtr) | +29.5% | +40.5% |
| Net profit growth (YoY) | -44.4% | +47.0% |
| Gross margin | 22.1% | 38.6% |
| Operating margin | 6.7% | 6.2% |
| Net margin | 3.6% | 12.2% |
| Return on equity | 2.3% | 3.8% |
| Analyst target vs. price | +7.2% | +7.0% |
| Analyst buy share | 100% | 92% |
| RSI (14) | 69 | 61 |
| 30-day volatility | 29.7% | 27.1% |
| Max drawdown, 1 year | -14.0% | -12.6% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- WELL is the largest of the group by market value.
- WELL has returned the most over the past year.
- WELL carries the lowest trailing P/E.
- AHR pays the highest dividend yield.
- WELL is growing revenue fastest.
- WELL keeps the most profit per dollar of sales.
- WELL has been the calmest stock over the last 30 days.